avexa closes apricitabine (atc) program..., page-28

Talking about PGL, it might be worth talking to them again, as they have gone nowhere since the PGL/AVX debacle.

Talking about regional licensing agreements, can someone tell me why this wasn't looked at several months ago ?

Drona can't be that stupid that he neglected the risk that none of the big pharma wouldn't be interested, and have a number of fall back options. Can he ?

Now that everything has been closed and staff being made redundant, it is going to be much harder to get a deal done.

Doesn't smell right at all.